1 asset in CTNNB1-Related Neurodevelopmental Disorder And/Or Vitreoretinopathy

Therapeutic assets addressing CTNNB1-Related Neurodevelopmental Disorder And/Or Vitreoretinopathy, rated under Floatz methodology v0.2 and sorted by current rating.